| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Panbela Therapeutics, Inc. | Director | Common Stock | 27 | $19.00 | $0.71 | Sep 12, 2023 | Direct |
| Panbela Therapeutics, Inc. | Director | Warrants (right to buy) | 49.5K | Oct 4, 2022 | Direct | ||
| Panbela Therapeutics, Inc. | Director | Stock Option (right to buy) | 8.33K | Mar 27, 2023 | Direct | ||
| Panbela Therapeutics, Inc. | Director | Common Stock | 0 | $0.71 | Sep 12, 2023 | Jointly with spouse |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| PBLA | Panbela Therapeutics, Inc. | Sep 12, 2023 | 1 | $0 | 4 | Sep 14, 2023 | Director |
| PBLA | Panbela Therapeutics, Inc. | Mar 27, 2023 | 1 | $0 | 4 | Mar 29, 2023 | Director |
| PBLA | Panbela Therapeutics, Inc. | Oct 4, 2022 | 2 | $0 | 4 | Oct 6, 2022 | Director |
| PBLA | Panbela Therapeutics, Inc. | Jun 15, 2022 | 0 | $0 | 3 | Jun 27, 2022 | Director |